Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/18/17
End: 07/13/20
Due: 07/13/21
Phase: N/A
Priority: Normal
Start: 01/31/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 03/31/26
Due: 03/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day | NCT03234465 | Oragenics, Inc. | user2@example.com | None | 2017-07-18 | 2020-07-13 | 2021-07-13 | - | - | 2025-07-14 |
| Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3) | NCT01520974 | Oragenics, Inc. | user2@example.com | None | 2012-01-31 | - | - | - | - | 2025-07-14 |
| A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury | NCT06870240 | Oragenics, Inc. | user2@example.com | None | 2025-06-01 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |